Skip to content

Clinical trials

Waldenstrom Macroglobulinemia trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Country / region: Poland Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20133
20171
20181
20191
20212
20222
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed4
Terminated2
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences3
Eli Lilly and Company2
BeiGene1
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.1
Hutchmed1
Janssen Research & Development, LLC1
Loxo Oncology, Inc.1
Merck Sharp & Dohme LLC1
Nurix Therapeutics, Inc.1
Polish Myeloma Consortium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia15
Lymphoma, B-Cell, Marginal Zone11
Lymphoma, Follicular11
Leukemia, Lymphocytic, Chronic, B-Cell10
Lymphoma, Mantle-Cell9
Lymphoma, Non-Hodgkin7
Lymphoma, Large B-Cell, Diffuse5
Lymphoma, B-Cell4
Dendritic Cell Sarcoma, Interdigitating2
Bronchiolitis Obliterans Syndrome1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.